Midazolam

Procedural sedation, anxiolysis, amnesia induction, anesthesia, continuous ICU sedation in mechanically ventilated patients, and treatment of status epilepticus are clinical applications for midazolam, a short-acting benzodiazepine with rapid onset. Laboratory testing applications include therapeutic drug monitoring in critically ill ICU patients where organ dysfunction may alter drug clearance and cause accumulation, forensic toxicology investigations of fatal overdose and poisoning cases, clinical toxicology assessments in hospitalized patients, and drug-facilitated crime investigations. UTAK’s Benzodiazepines Plus panels contain midazolam in urine and whole blood matrices at multiple concentration levels, supporting mass spectrometry confirmation methods used in clinical, forensic, and therapeutic drug monitoring applications. Stock and custom QC solutions can incorporate related benzodiazepines such as alprazolam, clonazepam, diazepam, lorazepam, oxazepam, temazepam, and other commonly monitored sedative-hypnotics to address your laboratory’s comprehensive testing requirements.